Edwards Lifesciences Corporation (EW)
After hours:
| Previous close | 65.37 |
| Open | 65.79 |
| Bid | 65.50 x 800 |
| Ask | 65.99 x 800 |
| Day's range | 64.05 - 65.83 |
| 52-week range | 58.93 - 96.12 |
| Volume | |
| Avg. volume | 6,825,589 |
| Market cap | 39.451B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 25.78 |
| EPS (TTM) | 2.54 |
| Earnings date | 23 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 76.58 |
GuruFocus.comVanguard Group Inc's Strategic Acquisition of Edwards Lifesciences Corp Shares
On September 30, 2024, Vanguard Group Inc made a significant addition to its portfolio by acquiring 9,018,094 shares of Edwards Lifesciences Corp (NYSE:EW), a prominent player in the medical devices sector. This transaction increased Vanguard's total holdings in the company to 62,594,108 shares, reflecting a substantial commitment to Edwards Lifesciences. Founded in 1975 by John C. Bogle, Vanguard Group Inc has grown into a leading global investment firm, renowned for its low-cost mutual funds and ETFs.
ZacksIs it the Right Time to Hold EW Stock in Your Portfolio Now?
Edward Lifesciences' Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.
Simply Wall St.Edwards Lifesciences Corporation (NYSE:EW) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
It is hard to get excited after looking at Edwards Lifesciences' (NYSE:EW) recent performance, when its stock has...
